|
| Age | Sex | Liver Cirrhosis | Malignancy | Chemotherapy | Antiviral Therapy | Follow up (Month) |
| 1. patient | 59 | f | no | Breast | TRANSTUZUMAB-PERTUZUMAB | ETV 0.5 | 16 |
| 2. patient | 70 | m | no | Gall Bladder | Gemcitabine + cddp | ETV 0.5 | 30 |
| 3. patient | 44 | f | no | Breast | AC | ETV 0.5 | 39 |
| 4. patient | 60 | f | no | Periton | Pacl + Carbo | ETV 0.5 | 27 (ex) |
| 5. patient | 60 | m | no | Prostate | Zoladex + docetaxel + enzalutamid +zometa | ETV 0.5 |
|
| 6. patient | 55 | m | no | Rectum | 5 FU, folfox-4 | ETV 0.5 | 39 |
| 7. patient | 66 | m | no | Lung | Gemcitabine | Lam 100 mg + TFV 245 mg | 41 (ex) |
| 8. patient | 72 | f | no | NHL (Large cell) | 5 years before, 6 cure chop Now R-ICE | TFV 245 mg + Lam 100 mg | 72 |
| 9. patient | 25 | f | no | Giant cell tm of bone | Proliakordexa | ETV 0.5 mg | 40 |
| 10. patient | 44 | f | no | NHL | BMT | ETV 1 mg | 10 |
| 11. patient | 46 | f | no | Breast | AC-Gemcitabine-Carboplatin-Doxataksel | TFV 245 mg | 50 |
| 12. patient | 70 | m | no | Laryngeal-Lung | Gemcitabine-Daksotaksel-cisplatin | Lam 100 mg | 48 |
| 13. patient | 49 | m | no | Testicular | CDDp-Carboplatin | Lam 100 mg | 74 |
| 14. patient | 61 | m | no | Prostate |
| Lam 100 mg | 72 |